May 1, 2026 1847 Holdings Reports Audited 2025 Results with 207% Revenue Growth to $48.3 Million; Net Income of $66.5 Million and Adjusted EBITDA of $9.8 Million
May 1, 2026 Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs